CURRENT FUNDING

NIH/NIAID R01AI143639 (DITTMANN)

ELF1 - Molecular mechanisms of a novel transcription factor with broad antiviral activity

The goal of this project is to characterize the transcription factor ELF1 in conferring broad antiviral activity, in vitro and in vivo.

NIH//NIAID R21AI139374 (DITTMANN)

SERPINs as a novel family of innate antiviral molecules

The goal of this project is to identify novel members of the serine protease inhibitor family that are critical for virus restriction in a polarized human airway epithelium model.

G. HAROLD AND LEILA Y. MATHERS CHARITABLE FOUNDATION

Identification of novel therapeutics for COVID-19

The goal of this project is to identify and characterize novel antivirals for SARS-CoV-2 infections, using in vitro and in vivo models.

THE VILCEK FOUNDATION (VALERO-JIMENEZ)

Postdoctoral Fellowship

NIH/NIAID T32AI17647 (PRESCOTT)

Training grant